These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33664858)

  • 1. Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction.
    Wen Z; Zhan J; Li H; Xu G; Ma S; Zhang J; Li Z; Ou C; Yang Z; Cai Y; Chen M
    Theranostics; 2021; 11(8):3725-3741. PubMed ID: 33664858
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
    Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    Boitard SE; Marc Y; Keck M; Mougenot N; Agbulut O; Balavoine F; Llorens-Cortes C
    J Mol Cell Cardiol; 2019 Feb; 127():215-222. PubMed ID: 30599150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATRQβ-001 vaccine improves cardiac function and prevents postinfarction cardiac remodeling in mice.
    Pan Y; Zhou Z; Zhang H; Zhou Y; Li Y; Li C; Chen X; Yang S; Liao Y; Qiu Z
    Hypertens Res; 2019 Mar; 42(3):329-340. PubMed ID: 30587854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Molitor M; Rudi WS; Garlapati V; Finger S; Schüler R; Kossmann S; Lagrange J; Nguyen TS; Wild J; Knopp T; Karbach SH; Knorr M; Ruf W; Münzel T; Wenzel P
    Cardiovasc Res; 2021 Jan; 117(1):162-177. PubMed ID: 32077922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes.
    Bäcklund T; Lakkisto P; Palojoki E; Grönholm T; Saraste A; Finckenberg P; Mervaala E; Tikkanen I; Laine M
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):66-73. PubMed ID: 17703432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
    Li C; Han R; Kang L; Wang J; Gao Y; Li Y; He J; Tian J
    Sci Rep; 2017 Jan; 7():40523. PubMed ID: 28091615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.
    Arendse LB; Danser AHJ; Poglitsch M; Touyz RM; Burnett JC; Llorens-Cortes C; Ehlers MR; Sturrock ED
    Pharmacol Rev; 2019 Oct; 71(4):539-570. PubMed ID: 31537750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
    Leenen FHH; Ahmad M; Marc Y; Llorens-Cortes C
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):82-91. PubMed ID: 30531435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
    Zimmermann M; Unger T
    Expert Opin Pharmacother; 2004 May; 5(5):1201-8. PubMed ID: 15155118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers.
    Pfeffer MA
    Am Heart J; 2000 Jan; 139(1 Pt 2):S23-8. PubMed ID: 10618584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.